Warfarin

CAS No. 81-81-2

Warfarin( Athrombine-K | WARF42 )

Catalog No. M19508 CAS No. 81-81-2

Warfarin(WARF42) is an anticoagulant drug normally used to prevent blood clot formation as well as migration.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Warfarin
  • Note
    Research use only, not for human use.
  • Brief Description
    Warfarin(WARF42) is an anticoagulant drug normally used to prevent blood clot formation as well as migration.
  • Description
    Warfarin(WARF42) is an anticoagulant drug normally used to prevent blood clot formation as well as migration.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Athrombine-K | WARF42
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    VKOR complex subunit 1
  • Research Area
    Cardiovascular Disease
  • Indication
    Thromboembolism

Chemical Information

  • CAS Number
    81-81-2
  • Formula Weight
    308.33
  • Molecular Formula
    C19H16O4
  • Purity
    >98% (HPLC)
  • Solubility
    H2O: < 0.1 mg/mL (insoluble); DMSO: ≥ 50 mg/mL (162.16 mM)
  • SMILES
    CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O
  • Chemical Name
    4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gebauer M. Bioorg Med Chem. 2007 15(6):2414-20.
molnova catalog
related products
  • Bruceine E

    Bruceine E is isolated from B. javanica seeds with hypoglycemia effects. Bruceine E can be used for studies about acting as an insulin secretagogue.

  • 2′-O-Methyluridine

    2′-O-Methyluridine is a natural product that found in RNA such as rRNA, snRNA, snoRNA and tRNA in Archaea, Bacteria, and Eukaryota.

  • Manool

    Manool, a diterpene from Salvia miltiorrhiza, showed antitumor activity in a mouse melanoma model.Manool caused cell cycle arrest in the G(2)/M phase of cancer cells, reducing the prevention of chromosomal damage and precancerous lesions.